|
⚲
|
| Keyboard |
| Celgene Alpine Investment Co LLC
✚
|
|
|---|---|
| CIK # | 0001581774 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001581774] | |
| SC 13G | [0001581774] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Celgene Alpine Investment Co LLC | Zymeworks Inc | [2017-05-05] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Celgene Switzerland LLC | |
| Celgene European Investment Co LLC | |
| Celgene Alpine Investment Co LLC | |
| Agios Pharmaceuticals Inc | |
| Celgene Corp /DE/ |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Agios Pharmaceuticals Inc AGIO
Common Stock
|
2019-11-12 | Buy | 403,225 | $31.00 | 12,499,975 |
|
Agios Pharmaceuticals Inc AGIO
Common Stock
|
2018-01-23 | Buy | 851,154 | $67.00 | 57,027,318 |
|
Agios Pharmaceuticals Inc AGIO
Common Stock
|
2017-04-24 | Buy | 624,575 | $49.50 | 30,916,462 |
|
Agios Pharmaceuticals Inc AGIO
Common Stock
|
2014-04-29 | Buy | 294,800 | $44.00 | 12,971,200 |
|
Agios Pharmaceuticals Inc AGIO
Series C-2 Convertible Preferred Stock · derivative
|
2013-07-29 | Conversion | 5,839,496 | $0.00 | |
|
Agios Pharmaceuticals Inc AGIO
Common Stock
|
2013-07-29 | Buy | 708,333 | $18.00 | 12,749,994 |
|
Agios Pharmaceuticals Inc AGIO
Common Stock
|
2013-07-29 | Conversion | 2,123,453 | ||
|
Agios Pharmaceuticals Inc AGIO
Series B Convertible Preferred Stock · derivative
|
2013-07-29 | Conversion | 5,190,551 | $0.00 | |
|
Agios Pharmaceuticals Inc AGIO
Common Stock
|
2013-07-29 | Conversion | 1,887,473 |